Literature DB >> 698732

Tricyclic antidepressant concentrations and clinical response.

.   

Abstract

Mesh：

Substances：

Year:  1978        PMID： 698732      PMCID： PMC1607789          DOI： 10.1136/bmj.2.6140.783

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  15 in total

1.  Routine nortriptyline levels in treatment of depression.

Authors:  S A Montgomery; R A Braithwaite; J L Crammer
Journal:  Br Med J       Date:  1977-07-16

2.  Plasma nortriptyline levels--relationship to clinical effects.

Authors:  M Asberg
Journal:  Clin Pharmacol Ther       Date:  1974-07       Impact factor: 6.875

3.  Plasma-nortriptyline levels in endogenous depression.

Authors:  P Kragh-Sørensen; M Asberg; C Eggert-Hansen
Journal:  Lancet       Date:  1973-01-20       Impact factor: 79.321

4.  Nortriptyline in depressed patients with high plasma levels. II.

Authors:  R Braithwaite; S Montgomery; S Dawling
Journal:  Clin Pharmacol Ther       Date:  1978-03       Impact factor: 6.875

5.  Antidepressant drug levels and clinical response.

Authors:  W Z Potter; F K Goodwin
Journal:  Lancet       Date:  1978-05-13       Impact factor: 79.321

6.  Amitriptyline plasma levels and clinical response in primary depression.

Authors:  D J Kupfer; I Hanin; D G Spiker; T Grau; P Coble
Journal:  Clin Pharmacol Ther       Date:  1977-12       Impact factor: 6.875

7.  A comparison study of amitriptyline and nortriptyline with plasma levels.

Authors:  V E Ziegler; P J Clayton; J T Biggs
Journal:  Arch Gen Psychiatry       Date:  1977-05

8.  High plasma nortriptyline levels in the treatment of depression. I.

Authors:  S Montgomery; R Braithwaite; S Dawling; R McAuley
Journal:  Clin Pharmacol Ther       Date:  1978-03       Impact factor: 6.875

9.  Nortriptyline plasma levels and therapeutic response.

Authors:  V E Ziegler; P J Clayton; J R Taylor; B Tee; J T Biggs
Journal:  Clin Pharmacol Ther       Date:  1976-10       Impact factor: 6.875

10.  Amitriptyline plasma-concentration and clinical effect. A World Health Organisation Collaborative Study.

Authors:  A Coppen; K Ghose; S Montgomery; V A Rama Rao; J Bailey; J Christiansen; P L Mikkleson; H M van Praag; F van de Poel; E J Minsker; V G Kozulja; N Matussek; G Kungkunz; A Jłrgensen
Journal:  Lancet       Date:  1978-01-14       Impact factor: 79.321
View more
  3 in total

Review 1.  Clinical relevance of pharmacokinetics.

Authors:  G Tognoni; C Bellantuono; M Bonati; M D'Incalci; M Gerna; R Latini; M Mandelli; M G Porro; E Riva
Journal:  Clin Pharmacokinet       Date:  1980 Mar-Apr       Impact factor: 6.447

Review 2.  Adverse effects of antidepressant drugs. Part 2: 'Second generation' antidepressants and rational decision making in antidepressant therapy.

Authors:  B Blackwell
Journal:  Drugs       Date:  1981-04       Impact factor: 9.546

3.  Pharmacokinetics of mefruside and two active metabolites in man.

Authors:  H L Fleuren; C P Verwey-van Wissen; J M van Rossum
Journal:  Eur J Clin Pharmacol       Date:  1980-01       Impact factor: 2.953
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.